Adalimumab Supplier-Buyer Network — Trade Flow Analysis

Name: Adalimumab Supplier-Buyer Trade Network Dataset — 67+ Indian Exporters, 12+ Importers, 53+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Adalimumab supplier network, Adalimumab buyers, pharmaceutical export India, Adalimumab trade data

TransData Nexus

Adalimumab

India Pharmaceutical Trade Intelligence

$1.2M67 Suppliers53 CountriesHS 30021500

ExportsIndia → VENEZUELA27.9%India → SRI LANKA20.0%

ImportsUNITED STATES → India$167.7K UNITED KINGDOM → India$28.5K

#1 Supplier: RELIANCE LIFE

Who Supplies Adalimumab? Top Manufacturers & Buyers 2026 — RELIANCE LIFE SCIENCES PRIVATE LIMITED Leads | TransData Nexus | TransData Nexus

1ZYDUS LIFESCIENCES LIMITED

ZYDUS LIFESCIENCES LIMITED is the first-largest Adalimumab exporter from India, with a market share of 27.9% and a total export value of $332.6K across 22 shipments. Their average shipment value of $15.1K is above the market average of $5.3K, suggesting premium or bulk contract pricing.

ZYDUS LIFESCIENCES LIMITED serves 1 named buyer in our database. TO THE ORDER OF PURC is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• TO THE ORDER OF PURC — $332.6K across 22 shipments (100.0% of this supplier's total exports)

Key Insight: ZYDUS LIFESCIENCES LIMITED's per-shipment value of $15.1K is 183% above the market average of $5.3K, consistent with large-order contracts or value-added formulations.

2RELIANCE LIFE SCIENCES PRIVATE LIMITED

RELIANCE LIFE SCIENCES PRIVATE LIMITED is the second-largest Adalimumab exporter from India, with a market share of 27.0% and a total export value of $321.9K across 20 shipments. Their average shipment value of $16.1K is above the market average of $5.3K, suggesting premium or bulk contract pricing.

RELIANCE LIFE SCIENCES PRIVATE LIMITED serves 5 named buyers in our database. BANK OF CEYLON - TRA is the dominant customer, accounting for 70.7% of this supplier's tracked business. Top customers include:

• BANK OF CEYLON - TRA — $227.7K across 14 shipments (70.7% of this supplier's total exports)

• LEVANT PULSE — $59.7K across 4 shipments (18.6% of this supplier's total exports)

• PHARMACHEM PRIVATE LIMITED — $18.6K across 1 shipments (5.8% of this supplier's total exports)

• PLANET PHARMACEUTICA — $8.6K across 1 shipments (2.7% of this supplier's total exports)

• ABC PHARMA SERVICES — $7.1K across 0 shipments (2.2% of this supplier's total exports)

Key Insight: RELIANCE LIFE SCIENCES PRIVATE LIMITED's per-shipment value of $16.1K is 201% above the market average of $5.3K, consistent with large-order contracts or value-added formulations.

3CADILA HEALTHCARE LIMITED

CADILA HEALTHCARE LIMITED is the third-largest Adalimumab exporter from India, with a market share of 11.3% and a total export value of $135.2K across 4 shipments. Their average shipment value of $33.8K is above the market average of $5.3K, suggesting premium or bulk contract pricing.

CADILA HEALTHCARE LIMITED serves 2 named buyers in our database. XXALTXXAREXXHARXXCEU is the dominant customer, accounting for 87.0% of this supplier's tracked business. Top customers include:

• XXALTXXAREXXHARXXCEU — $117.6K across 3 shipments (87.0% of this supplier's total exports)

• XXTERXXLABXXNIGXXIA — $17.6K across 1 shipments (13.0% of this supplier's total exports)

Key Insight: CADILA HEALTHCARE LIMITED's per-shipment value of $33.8K is 532% above the market average of $5.3K, consistent with large-order contracts or value-added formulations.

4REMEDI PHARMA DISTRIBUTORS

REMEDI PHARMA DISTRIBUTORS is the fourth-largest Adalimumab exporter from India, with a market share of 5.2% and a total export value of $62.0K across 5 shipments. Their average shipment value of $12.4K is above the market average of $5.3K, suggesting premium or bulk contract pricing.

REMEDI PHARMA DISTRIBUTORS serves 1 named buyer in our database. DAWAA DRUG STORE LLC is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• DAWAA DRUG STORE LLC — $62.0K across 5 shipments (100.0% of this supplier's total exports)

Key Insight: REMEDI PHARMA DISTRIBUTORS's per-shipment value of $12.4K is 132% above the market average of $5.3K, consistent with large-order contracts or value-added formulations.

5PHARMA CHOICE LLP

PHARMA CHOICE LLP is the fifth-largest Adalimumab exporter from India, with a market share of 4.7% and a total export value of $55.5K across 23 shipments. Their average shipment value of $2.4K is below the market average of $5.3K, reflecting a high-volume, competitive pricing strategy.

PHARMA CHOICE LLP serves 4 named buyers in our database. D. K. M. PHARMACEUTICALS PVT. LTD. is the dominant customer, accounting for 69.3% of this supplier's tracked business. Top customers include:

• D. K. M. PHARMACEUTICALS PVT. LTD. — $38.4K across 16 shipments (69.3% of this supplier's total exports)

• D. K. M. PHARMACEUTICALS PVT. LTD. — $17.0K across 7 shipments (30.6% of this supplier's total exports)

• PSK PHARMA LTD — $59 across 0 shipments (0.1% of this supplier's total exports)

• ALGENPHARM — $19 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: PHARMA CHOICE LLP operates with high shipment frequency (23 shipments) at a per-shipment value of $2.4K, indicating a broad distribution network with many smaller, regular orders.

6SPECIALITY PHARMA

SPECIALITY PHARMA is the fifth-largest Adalimumab exporter from India, with a market share of 3.1% and a total export value of $37.5K across 4 shipments. Their average shipment value of $9.4K is above the market average of $5.3K, suggesting premium or bulk contract pricing.

SPECIALITY PHARMA serves 2 named buyers in our database. D K M PHARMACEUTICALS PVT LTD is the dominant customer, accounting for 93.6% of this supplier's tracked business. Top customers include:

• D K M PHARMACEUTICALS PVT LTD — $35.1K across 4 shipments (93.6% of this supplier's total exports)

• D K M PHARMACEUTICALS PVT LTD — $2.4K across 0 shipments (6.4% of this supplier's total exports)

Key Insight: SPECIALITY PHARMA's per-shipment value of $9.4K is 75% above the market average of $5.3K, consistent with large-order contracts or value-added formulations.

1Venezuela

Venezuela ranks as the first-largest destination for Adalimumab imports from India, with a total trade value of $332.6K across 0 shipments — representing a 27.9% share of all Adalimumab exports. The average shipment value of $332.6K is above the global average of $5.3K, indicating high-value procurement contracts or branded formulations.

Key Insight: Venezuela's per-shipment average of $332.6K (6120% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Venezuela is a key market for Adalimumab imports from India.

Primary Market

Secondary Market

2Sri Lanka

Sri Lanka ranks as the second-largest destination for Adalimumab imports from India, with a total trade value of $238.3K across 0 shipments — representing a 20.0% share of all Adalimumab exports. The average shipment value of $238.3K is above the global average of $5.3K, indicating high-value procurement contracts or branded formulations.

Key Insight: Sri Lanka's per-shipment average of $238.3K (4356% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Sri Lanka is a key market for Adalimumab imports from India.

Primary Market

Secondary Market

3Nepal

Nepal ranks as the third-largest destination for Adalimumab imports from India, with a total trade value of $130.3K across 28 shipments — representing a 10.9% share of all Adalimumab exports. The average shipment value of $4.7K is below the global average of $5.3K, consistent with generic/API volume purchasing. This market is served by 4 tracked buyers.

Named Adalimumab importers in Nepal: D. K. M. PHARMACEUTICALS PVT. LTD. is the largest buyer, accounting for 38.2% ($49.8K) of this market's total imports.

• D. K. M. PHARMACEUTICALS PVT. LTD. — $49.8K (38.2% of Nepal's total)

• D K M PHARMACEUTICALS PRIVATE LIMITED — $35.1K (26.9% of Nepal's total)

• PHARMACHEM PRIVATE LIMITED — $22.7K (17.4% of Nepal's total)

Key Insight: Nepal receives frequent, smaller shipments of Adalimumab — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Nepal is a key market for Adalimumab imports from India.

Primary Market

Secondary Market

4Bangladesh

Bangladesh ranks as the fourth-largest destination for Adalimumab imports from India, with a total trade value of $117.6K across 0 shipments — representing a 9.9% share of all Adalimumab exports. The average shipment value of $117.6K is above the global average of $5.3K, indicating high-value procurement contracts or branded formulations.

Key Insight: Bangladesh's per-shipment average of $117.6K (2099% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Bangladesh is a key market for Adalimumab imports from India.

Primary Market

Secondary Market

5United Arab Emirates

United Arab Emirates ranks as the fifth-largest destination for Adalimumab imports from India, with a total trade value of $78.9K across 2 shipments — representing a 6.6% share of all Adalimumab exports. The average shipment value of $39.5K is above the global average of $5.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Adalimumab importers in United Arab Emirates: IMAD SOUHEL ANDRAOS is the largest buyer, accounting for 17.1% ($13.5K) of this market's total imports.

• IMAD SOUHEL ANDRAOS — $13.5K (17.1% of United Arab Emirates's total)

Key Insight: United Arab Emirates's per-shipment average of $39.5K (638% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Arab Emirates is a key market for Adalimumab imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Adalimumab.
2.Flow Mapping: 67 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 223 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 53 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

223 Verified Shipments

67 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Adalimumab

Adalimumab

Who Supplies Adalimumab? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Adalimumab? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Adalimumab Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1ZYDUS LIFESCIENCES LIMITED

2RELIANCE LIFE SCIENCES PRIVATE LIMITED

3CADILA HEALTHCARE LIMITED

4REMEDI PHARMA DISTRIBUTORS

5PHARMA CHOICE LLP

6SPECIALITY PHARMA

From Indian Factories to Global Pharmacies — How Adalimumab Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Adalimumab Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Venezuela

2Sri Lanka

3Nepal

4Bangladesh

5United Arab Emirates

People Also Ask — Adalimumab Supplier & Trade Network

Adalimumab Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology